ClinicalTrials.gg
CompletedNCT01643057Updated Sep 10, 2015

Stochastic Resonance Mattress (Physiological Interventions) and Biomarkers for Enhancing Neonatal Health

An observational study in Apnea of Prematurity, sponsored by Wyss Institute at Harvard University. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2015-09-10.

Sponsored by Wyss Institute at Harvard University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
36
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 85 studies in Apnea with a site in United States — 15 open to participants now, 18 under way, 2 of them phase 3. Apnea · United States.

Enrollment
15th of 16
36 · median 113
Started
2012
with 7 others
Observational
16 of 85
1 open now
Registered
25th of 85
by date

Among the 85 studies in Apnea with a site in United States, this one is the 15th largest by enrollment of the 16 observational ones that give a count, is one of 8 that started in 2012, is one of 16 observational ones, and was the 25th registered.

Apnea

283 studies on the registry are indexed under Apnea; 55 are open to participants now.

Browse Apnea studies →

Open to participants now

15 of the 85 studies in Apnea with a site in United States are open now. Recruiting first, the newest first:

10 more — sign in →

All 15 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 40 Apnea studies recruiting now, 9 (23%) set no upper age limit and 27 (68%) stop at 75 or younger; 19 take children under 18; 16 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 85 studies in Apnea with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to explore physiological interventions and biomarkers for Apnea of Prematurity in newborn infants.

Read the detailed description

Apnea of prematurity is defined as cessation of breathing that lasts for more than 20 seconds and/or is accompanied by oxygen desaturation or a decrease in heart rate (bradycardia). Because apnea presents itself within a variety of diseases in newborns, its diagnosis is based largely on the exclusion of other findings. The difficulty in relating the manifestation of apnea to its cause can lead to issues regarding appropriate medical management and delays in treatment.

Our exploration of physiological interventions for Apnea of Prematurity begins with stochastic resonance. Stochastic resonance is the introduction of noise to a system, to alter the system's behavior. This technology has been examined in previous medical applications. The hypothesis for this work is that stochastic resonance stimulation, in the form of gentle vibrations, will stabilize immature breathing patterns in infants.

In this research study, we will use an apnea mattress developed by engineers at the Wyss Institute, Harvard University, which provides gentle vibrations to the infant. We will closely follow the research protocol from UMass Medical School. Whilst the infant is on the mattress, clinical care data will be collected to determine effect on breathing patterns. We also hope to collect enough baseline and intervention data signals to be able to identify candidate biomarkers for apnea. This will assist in development of predictive algorithms for apnea in infants.

03

Conditions studied

  • Apnea of Prematurity

Keywords

  • Apnea
  • Prematurity
  • Biomarkers
  • Stochastic Resonance
  • Neonatal
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Infants currently inpatient in the Neonatal Intensive Care Unit at Beth Israel Deaconess Medical Center.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Eligible subjects are infants currently inpatient in the NICU at Beth Israel Deaconess Medical Center and:

  • Born premature, at a gestational age \< 36 weeks
  • Demonstrate irregular breathing by having had at least one documented clinical apnea (> 20 seconds), bradycardia (\< 100 bpm) and/or desaturation (\< 90%)

Exclusion criteria

Exclusion Criteria:

Eligible infants meeting the inclusion criteria above will be excluded from participation in the study if he/she:

  • Is at a Post Conceptual Age of > 45 weeks at time of study (Calculated as: weeks of age at birth + weeks of age since birth)
  • Has demonstrable pulmonary disease at time of study, i.e. Chronic Lung Disease, Infant Respiratory Distress Syndrome
  • Has Hypoxic-Ischemic Encephalopathy including a cord pH of ≤ 7
  • Has a congenital abnormality
  • Has a genetic syndrome
  • Has an anatomic brain anomaly
  • Has hydrocephalus or intraventricular hemorrhage > Grade 3 or 4
  • Is anemic ( \< 8g/dL)
  • Has an infection at time of study
  • Is undergoing therapeutic hypothermia
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
36 participants (actual)

Groups and cohorts

  • Stochastic Resonance Mattress

    The infant's isolette mattress will be replaced with a specially designed mattress (non-commercially available, designed by engineers at the Wyss Institute, Harvard University) to provide gentle vibrations and sounds during mattress stimulations.

    Device: Stochastic Resonance Mattress

Interventions

  • DeviceStochastic Resonance Mattress

    The infant's isolette mattress will be replaced with a specially designed mattress (non-commercially available, designed by engineers at the Wyss Institute, Harvard University) to provide gentle vibrations and sounds during mattress stimulations.

06

What researchers measure

Primary outcomes

  1. Investigate effects of mattress intervention on breathing patterns

    Focus on inter-breath intervals and oxygen desaturation.

    Time frame: Each study session may last up to 24 hours. Participants may take part in up to 4 study sessions.

Secondary outcomes

  1. Candidate Biomarkers for Apnea of Prematurity

    Candidate biomarkers in cardio-pulmonary, temperature, audiometry, photometry and clinical assessment data.

    Time frame: Each study session may last up to 24 hours. Participants may take part in up to 4 study sessions.

07

Study locations

1 site
  • Beth Israel Deaconness Medical Center
    Boston, Massachusetts 02115, United States
08

References and documents

Publications

  • Smith VC, Kelty-Stephen D, Qureshi Ahmad M, Mao W, Cakert K, Osborne J, Paydarfar D. Stochastic Resonance Effects on Apnea, Bradycardia, and Oxygenation: A Randomized Controlled Trial. Pediatrics. 2015 Dec;136(6):e1561-8. doi: 10.1542/peds.2015-1334. PubMed 26598451 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2012, a primary completion of Jul 2014 and a completion of Jul 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 13, 2012
First posted
Jul 17, 2012
Start
Jul 2012
Primary completionActual
Jul 2014
CompletionActual
Jul 2014
Last update
Sep 10, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01643057
Lead sponsor
Wyss Institute at Harvard University
Responsible party
Sponsor
First posted
Jul 17, 2012
Start date
Jul 2012
Primary completion
Jul 2014
Completion
Jul 2014
Last update
Sep 10, 2015

Study contacts

Vincent C Smith, MD, MPH
principal investigator · Beth Israel Deaconess Medical Center
David Paydarfar, MD
principal investigator · UMASS Medical School

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion